DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]

Clinical trial NCT03329690 · COMPLETED

Trial details

NCT number: NCT03329690
Sponsor: Daiichi Sankyo Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasm, Gastrointestinal

Start date: 2017-11-02
Primary completion: 2019-11-08
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.